RecruitingNot ApplicableNCT06984562

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer: Phase I Dose Escalation Study


Sponsor

Fox Chase Cancer Center

Enrollment

16 participants

Start Date

Aug 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer. The main questions the study aims to answer are: * Can ART improve how well radiation therapy targets the most aggressive cancer cells, while protecting the healthy tissue around the tumor? * Can ART help reduce the side effects that participants may experience during treatment? Participants will: * Undergo CT scans to plan the exact location of the radiation treatment. During this process, 1-3 small markers may be placed in or near the tumor to help with the planning. * Have a tumor biopsy, which involves taking a small sample of tissue from the cancer. * Receive 5 radiation treatments every other day over a 2-week period. * Provide blood samples before, during, and after your radiation treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a type of radiation therapy called adaptive radiation therapy (ART) for people with locally advanced pancreatic cancer that cannot be surgically removed. Adaptive radiation uses real-time imaging during each treatment session to adjust the radiation beams around the tumor — potentially delivering higher, more effective doses while protecting nearby organs like the stomach and intestines. **You may be eligible if...** - You have been confirmed by biopsy or cytology to have pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer) - Your cancer is locally advanced and cannot be surgically removed (as determined by a multidisciplinary team including a pancreatic surgeon) - You have received or been evaluated for induction chemotherapy before radiation - You are in adequate physical condition to tolerate the treatment **You may NOT be eligible if...** - Your cancer has already spread to other organs (metastatic disease) - You have had prior radiation to the same area of the abdomen - You are unable to complete the required imaging and treatment sessions due to health limitations - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONAdaptive Radiation Therapy

Adaptive Radiation Therapy (ART) creates a personalized radiation plan for each treatment session. This means the plan can change from day to day to more precisely target the tumor while protecting the surrounding healthy tissue. By closely shaping the radiation to match the tumor's location, ART may reduce the amount of radiation reaching nearby normal tissues. This can allow for higher, more focused doses of radiation to the tumor itself, which may help improve treatment effectiveness while reducing side effects.


Locations(1)

Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06984562